CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow -0.4% ·
net new positions -7.7%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 5.53M | -4.6% | $134.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 2.96M | +9.2% | $71.69M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 2.77M | +3.8% | $67.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.77M | +3.8% | $67.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 1.04M | +48.2% | $25.10M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 977.62K | -19.6% | $23.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 977.62K | -19.6% | $23.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 685.42K | +57.0% | $16.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 685.42K | +57.0% | $16.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 303.53K | -41.7% | $7.36M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 100.39K | +452.4% | $2.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 82.17K | -5.4% | $1.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 47.31K | +21.4% | $1.15M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Norges Bank ✦ (passive) | 13.77K | -85.0% | $333,826 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $5.29M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 378 holders, 103.75M shares, $2.50B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.